![Adeel Ahmed-Daudpota](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Adeel Ahmed-Daudpota
Algemeen Directeur bij IMMUNE PHARMACEUTICALS, INC.
Actieve functies van Adeel Ahmed-Daudpota
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
IMMUNE PHARMACEUTICALS, INC. | Algemeen Directeur | 12-04-2021 | - |
President | 12-04-2021 | - |
Loopbaan van Adeel Ahmed-Daudpota
Statistieken
Internationaal
Verenigde Staten | 2 |
Operationeel
Chief Executive Officer | 1 |
President | 1 |
Sectoraal
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Immune Pharmaceuticals, Inc.
![]() Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Its lead product, Bertilimumab, is a human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to the site of inflammation. Bertilimumab has shown promising clinical activity in bullous pemphigoid and has been studied in other conditions including allergic rhinitis and ulcerative colitis, and may have application in other diseases, including atopic dermatitis, asthma, and other diseases. It is also developing NanoCyclo, a topical nano-encapsulated formulation of cyclosporine, for the treatment of atopic dermatitis (AD) and psoriasis. The company was founded by Daniel Gedeon Teper on March 9, 1993 and is headquartered in Englewood Cliffs, NJ. | Health Technology |